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Abstract Neural tube defects are severe malformations af-
fecting 1/1,000 live births. The planar cell polarity pathway
controls the neural tube closure and has been implicated in
the pathogenesis of neural tube defects both in animal mod-
els and human cohorts. In mouse disruption of Dvl2 alone
(Dvl2−/−) or Dvl2 and Dvl3 (Dvl2−/−; Dvl3+/−, Dvl2+/−;
Dvl3−/−) results in incomplete neurulation, suggesting a role
for Disheveled in neural tube closure. Disheveled is a mul-
tifunctional protein that is involved in both the canonical
Wnt signaling and the noncanonical planar cell polarity
pathway. In this study, we analyzed the role of the human
orthologs DVL2 and DVL3 in a cohort of 473 patients with
neural tube defects. Rare variants were genotyped in 639
ethnically matched controls. We identified seven rare mis-
sense mutations that were absent in all controls analyzed.
Two of these mutations, p.Tyr667Cys and p.Ala53Val, iden-
tified in DVL2 were predicted to be detrimental in silico.
Significantly, a 1-bp insertion (c.1801_1802insG) in exon
15 of DVL2 predicted to lead to the truncation of the protein
was identified in a patient with a complex form of caudal
agenesis. In summary, we demonstrate a possible role for
rare variants in DVL2 gene as risk factors for neural tube
defects.
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Introduction
Neural tube defects (NTDs; OMIM 182940) are a group of
birth anomalies resulting from failure of fusion of the neural
tube around the 28th day after conception. NTDs are known
to occur in 1 out every 1,000 pregnancies in the USA, with
varying rates reported among the world's populations (Botto
et al. 1999; Kibar et al. 2007a). The most common NTDs are
anencephaly, which results from failure of fusion of the
cranial neural tube and myelomeningocele (commonly
called spina bifida), which results from the failure of fusion
of the neural tube in the spinal region. Failure of closure that
involves the entire body axis is known as craniorachischisis
that is an additional, lethal, and relatively rare form of
dysraphism. Anencephaly and myelomeningocele are re-
ferred as “open” NTDs because the affected region is ex-
posed to the body surface. There are also a number of closed
or skin-covered conditions that involve the neural tube,
including encephalocele, meningocele, lipomeningocele, al-
so referred to as spina bifida occulta, and sacral agenesis
(Rossi et al. 2004).
NTDs have a multifactorial etiology involving both en-
vironmental and genetic factors. Although folic acid, sup-
plemented in the mother's diet periconceptionally, appears to
have dramatically reduced the frequency of NTDs (MRC
Vitamin Study Research Group 1991; Czeizel and Dudás
1992), the mechanism by which folate deficiency predispo-
ses to NTDs remains unclear.
Consistent efforts in many research fields have focused
toward understanding the mechanisms underlying the etiol-
ogy of these devastating defects. Nevertheless, few candi-
date genes have proved to contribute to the development of
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NTDs. Of the genes that have been associated with NTDs,
planar cell polarity (PCP) genes have been implicated as
predisposing factors of isolated nonsyndromic NTDs (De
Marco et al. 2011). The PCP pathway, a highly conserved,
noncanonical Wnt-frizzled-disheveled signaling cascade,
plays a key role in establishing and maintaining polarity in
the plane of epithelia in Drosophila and in epithelial and
nonepithelial tissues in vertebrates (Strutt 2003; Klein and
Mlodzik 2005). Genetic studies of mutants affecting com-
plex structures in the fly have identified a group of proteins
referred to as “core” PCP components, that include trans-
membrane proteins such as Frizzled (Fz), Strabismus/Van
Gogh (Stbm/Vang), and Flamingo (Fmi), as well as cyto-
plasmic proteins, including Disheveled (Dsh/Dvl), Prickle
(Pk), and Diego (Dgo) (Jenny and Mlodzik 2006; Jones and
Chen 2007).
The multifunctional protein Disheveled (Dsh in fly,
XDsh in Xenopus, and Dvl1, Dvl2 and Dvl3 in mammals)
is involved in both the canonical Wnt signaling pathway as
well as the PCP pathway (Mlodzik 2002; Strutt 2002; Tree
et al. 2002a; Wallingford and Harland 2002; Veeman et al.
2003a; Wallingford and Habas 2005) and regulates many
biological processes, ranging from cell-fate specification
and cell polarity to social behavior. In the canonical Wnt
pathway, Dsh is important in transmitting a signal initiated
from Wnt binding to its receptor Frizzled and coreceptor
Arrow/Lrp5/6 on the cell surface. As a consequence, the
cytoplasmic protein Armadillo/β-catenin becomes stabi-
lized and is transported into the nucleus to activate tran-
scription of target genes (He et al. 2004; Wang and
Wynshaw-Boris 2004). In the PCP pathway in the fly, Dsh
participates with a different set of proteins such as
Strabismus (Stbm), Prickle (Pk), Diego (Dgo), and
Flamingo (Fmi) (Das et al. 2002; Jenny et al. 2005; Strutt
2002; Tree et al. 2002b; Veeman et al. 2003b). Although the
precise mechanisms by which Dsh determines PCP signal-
ing is not well defined, an asymmetric plasma membrane
localization of Dsh and the other PCP members appears to
be required for proper signaling of the PCP pathway in the
fly (Axerold 2001; Strutt 2002; Tree et al. 2002a, b; Bastock
et al. 2003; Jenny et al. 2003, 2005; Rawls and Wolff 2003;
Veeman et al. 2003a; Das et al. 2002). Downstream effectors
of Disheveled in the PCP pathway include the forming-
homology protein DAAM1, two small GTPases, RhoA
and Rac, and the kinases ROCK and JNK (Habas et al.
2001, 2003; Kim and Han 2005). All these proteins mediate
cytoskeletal reorganization to induce cellular polarization,
directed migration, and protrusive activity in migrating
cells.
Disheveled proteins are 500–600 amino acids in length
and are modular. They function as essential scaffold proteins
that interact with diverse proteins, including kinases, phos-
phatases, and adaptor proteins. They contain three highly
conserved domains: the DIX (Disheveled/Axin) domain that
is largely α-helical structure (Capelluto et al. 2002), the
PDZ (PSD-95, DLG,ZO1) domain, which consists of six
β-sheets that enfold two α-helices (Wong et al. 2003), and
the DEP (Disheveled, EGL-10, Pleckstrin) domain, consist-
ing of a bundle of three α-helices domain (Wong et al.
2000). Several additional conserved regions are considered
critical for biological function: the serine/threonine stretches
between the DIX and PDZ domains, and the proline-rich
regions with a SH3 protein-binding domain motif down-
stream of the PDZ. The central PDZ and the DEP domains
function in noncanonical PCP signaling.
Mutants of Disheveled which correspond to mutations in
Drosophila that selectively impair PCP signaling were found
to disrupt convergent extension when expressed in Xenopus
(Wallingford et al. 2000) or zebrafish (Heisenberg et al. 2000).
In mouse,Dvl1−/−,Dvl3−/− single mutants andDvl1−/−;Dvl3−/
− double mutants do not display neural tube defects (Lijam et
al. 1997; Wang et al. 2006). Dvl2−/− embryos displayed tho-
racic spina bifida, while virtually all Dvl1−/−; Dvl2−/− double
mutant embryos displayed craniorachishisis, a completely
open neural tube from the midbrain to the tail (Hamblet et
al. 2002; Wang et al. 2006). For Dvl3, neurulation appeared
normal both in Dvl3−/− and LtapLp/+(Vangl2/Ltap) mutants,
while defects were seen in bothDvl3+/−; LtapLp/+ andDvl3−/−;
LtapLp/+ mutants, indicating genetic interaction between the
Dvl genes and the other PCP gene Vangl2 (Etheridge et al.
2008). These findings indicate thatDvl2 is the most important
mammalian Dvl gene for neural tube closure and is sufficient
by itself for the correct process. By contrast,Dvl1 andDvl3 are
not sufficient by themselves but contribute significantly when
Dvl2 is completely missing (Wu et al. 2011).
In view of these data and given the implication of PCP
signaling in NTDs, we investigated if the human orthologs
DVL2 and DVL3 genes could play a role in NTDs
pathogenesis.
Patients and Methods
The patient cohort consisted of (a) 391 Italian patients
recruited at the Spina Bifida Center of the Gaslini Hospital
in Genova, Italy; (b) 82 patients (mainly French-Canadian)
recruited at Sainte Justine Hospital in Montreal, Canada.
Both groups were already included in our previous studies
(Kibar et al. 2007b, 2009, 2011; De Marco et al. 2012). All
patients had isolated nonsyndromic NTDs. Around 19 % of
patients had a positive family history documented by clini-
cal records (MRI and X-ray images).
The control group comprised 433 Italian individuals and
206 Caucasian controls of French-Canadian ancestry previ-
ously enrolled for our genotyping study (De Marco et al.
2012). All control individuals (N0639) were seen by a
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neurologist and confirmed to be healthy. Samples from
patients and controls were collected with the approval of
the Local Ethics Committees, and written informed consent
was obtained from all participating patients, parents, and
controls.
Resequencing and Genotyping
Genomic DNA was isolated from EDTA peripheral blood
samples, by using the QIAamp DNA blood Kit (Qiagen),
according to the manufacturer's protocol. The genomic
structures of human DVL2 and DVL3 were determined using
the NCBI GenBank (DVL2, NM_004422.2; DVL3,
NM_004423.3). Primers flanking the exon–intron junctions
were developed manually. The whole coding region of
DVL2 (3,046-bp long) and DVL3 (5,062-bp long) with
180 bp of the 5′-untranslated region (UTR) and 150 bp of
the 3′UTR was amplified in a total of 10–12 amplicons for
each gene. The portions of the introns that were sequenced
ranged from 120 to 160 bp with an average of almost
140 bp. Polymerase chain reaction (PCR) was carried out
using the AmpliTaqGold (Applied Biosystems) as per man-
ufacturer's instructions. Direct dye terminator sequencing of
PCR products was carried out using the ABI Prism Big Dye
Systems (Applied Biosystems). Samples were run on ABI
3700 automated sequencer and analyzed using the
PhredPhrap software 5.04 (http://droog.gs.washington.edu/
polyphred). Nonsynonymous changes that were most likely
expected to have a detrimental effect were further genotyped
using the iPLEX™ Gold assay for SNP Genotyping
(Sequenom, San Diego, CA) (Ehrich et al. 2005). For var-
iants identified in NTDs cases, we tested the cosegregation
by sequencing the corresponding fragment in available ad-
ditional family members.
Bioinformatics
Mutations were annotated according to the HGVS nomencla-
ture (http://www.hgvs.org/mutnomen). Nucleotide numbering
reflects cDNA numbering with +1 corresponding to the A of
the ATG translation initiation codon 1 in the reference se-
quence. All sequence variations were queried against three
public databases: the dbSNP Build 133, the 1,000 Genome
Project (release of May 2011), and the NHLBI GO Exome
Sequencing Project (http://snp.gs.washington.edu/EVS/). To
predict the likelihood that an amino acid change is deleterious,
we used two software programs: PolyPhen (polymorphism
phenotyping) (http://genetics.bwh.harvard.edu/pph/) and
SIFT (Sorting Intolerant from Tolerant software). Default
conditions were used for the programs. Nonfunctional rare
variants have been checked for creation of cryptic splice sites
using computational method alternative splice site predictor
(http://www.es.embnet.org/~mwang/assp.html). Multiple
alignments of the DVL2 and DVL3 proteins were done using
the CLUSTAL W program, freely available online (http://
npsa-pbil.ibcp.fr). Localization of the variants in protein
domains were assessed by Uniprot (http://www.uniprot.org/).
Potential effect of the 3′UTR variants by altering
MicroRNA (miRNA) binding sites was evaluated by
MicroRNA.org site (http://www.microrna.org) that uses the
mirSVR regression model for target site predictions
(mirSVR score≤−0.1).
Association Analysis
Differences in mutation burden between patients and con-
trols were assessed by two-sided t tests, using SPSS version
16.0.2 (Brussels, Belgium).
Results
We report a genetic molecular study of DVL2 and DVL3 by
resequencing a large cohort of 473 NTD patients to test the
hypothesis whether a defective PCP signaling resulting from
mutations in DVL genes could represent a common under-
lying pathogenic mechanism.
We detected a total of eight rare mutations (<1 %) in
patients, five in DVL2 and three in DVL3, that were not
present in all controls analyzed. With the exception of DVL2
p.Ala53Val, all of them were novel and not reported in the
public databases (Table 1). All these mutations were found
in a heterozygote state, and all were private. They included a
1-bp insertion (c.1801_1802insG) in exon 15 of DVL2
predicted to lead to a premature truncation of the protein
(p.Glu620X) and seven missense mutations mainly local-
ized in the C-terminal of the protein. The 1-bp insertion in
exon 15 of DVL2 was detected in a girl affected by caudal
agenesis and tethered cord. Parents were not available for
the genetic testing. The mutation introduces a premature
stop codon at position 620 and truncated the protein that
lacked the last 116 amino acids in its carboxyl-terminal tail.
The majority of the missense mutations affected conserved
amino acid residues among DVLs orthologs (data not
shown). Two out seven missense mutations (DVL2
p.Tyr667Cys and DVL2 p.Ala53Val) were predicted to be
damaging or having functional relevance according to the
SIFT program. The two missense changes of DVL2,
p.Tyr667Cys and p.Ala53Val, were found in two sporadic
cases of NTDs, having myelomeningocele and lipoma, re-
spectively. Interestingly, the p.Ala53Val affects the amino-
terminal DIX domain which mediates dynamic polymeriza-
tion, essential for signaling activity of DVL2 (Schwarz-
Romond et al. 2007). The DVL2 p.Ala53Val (rs149736410)
was detected twice among 2,500 exomes included in the
NHLBI Exome Sequencing Project at a frequency of 0.001.
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None of the three DVL3 missense variants detected in
patients and absent in controls caused significant changes in
the protein function since they were scored as neutral by the
two algorithms. Moreover, these mutations did not create
cryptic splice sites, suggesting that they did not affect the
gene splicing.
A single nucleotide substitution (c.*49 G>C) affecting
the 3′UTR of the DVL3 gene, outside of protein coding
sequence, was also identified in one patient (data not
shown). Potential effect of this novel rare variant by altering
miRNA binding sites was evaluated, but no evident effect
was demonstrated. Detailed clinical information on patients
carrying rare mutations of DVLs are presented in
Supplementary Table 1.
To assess the rate of rare pathogenic mutations in DVL2
and DVL3 in the normal population, we therefore rese-
quenced the coding sequence and exon–intron boundaries
of the two genes in a cohort of 150 ethnically matched
controls. We could detect one missense mutation in DVL2,
p. Ser358Phe, and one in DVL3, p. Ser175Gly, in two
healthy individuals. The DVL2 p. Ser358Phe and the
DVL3 p. Ser175Gly gene variants were predicted to affect
protein function in silico (Table 1). There was no significant
difference in overall mutation burden between the geno-
typed patients (nine nonsynonymous rare variants/473) and
controls (two nonsynonymous rare variants/150).
Nevertheless, when only DVL2 variants were taken into
account, the overall rate of predicted deleterious variants
causing amino acid substitutions (including frameshifts)
were 1.2-fold higher in cases compared to controls (4/473
in patients vs 1/150 in controls), although this trend did not
reach the significance (p01).
In addition to these rare mutations, we found a common
variant, the DVL2 p.Thr535Ile (rs72839768), at a frequency
of 1 % in patient group. This variant was not conserved and
was predicted to be damaging; nevertheless, an association
study between case and control groups demonstrated no
significant association of this SNP with NTD phenotype
(data not shown).
The patient group belongs to a cohort already analyzed
for mutations in other PCP genes VANGL1, VANGL2,
PRICKLE1, CELSR1, FZD3, and FZD6 (Kibar et al. 2009,
2011; Bosoi et al. 2011; Allache et al. 2012; De Marco et al.
2012). While no NTD patient and control was a carrier of
rare missense mutations in both DVL2 and DVL3, we could
identify four patients that were double heterozygotes for
variants in one of the DVL genes and in another core PCP
gene (Table 2).
Discussion
Disheveled (DVL) proteins are important signaling compo-
nents of both the canonical Wnt signaling pathway, which
Table 1 Novel rare mutations
(<1 %) identified in DVL2 and
DVL3 in human cohorts
AA amino acid, Polyphen poly-
morphism phenotyping soft-
ware, SIFT Sorting Intolerant
from Tolerant software
aAll the nonsynonymous var-
iants identified in patients were
genotyped in 639 controls
bPolyphen predictions for amino
acid changes: “++” for probably
damaging “+” for possibly dam-
aging; “−” for benign
cSIFT predictions for amino acid
changes: “+” predicted to affect
protein function; “−” predicted
to be tolerated
dThe variant is present in data-
base as rs149736410
eThe variant is present in data-
base as rs149103009







c.158C>T p.Ala53Vald 1 0 − + DIX
c.1073C>T p.Ser358Phe 1 1 + + Proline-rich region
c.1801_1802insG p.Glu620X 1 0 N/A N/A C-terminal
c.2000A>G p.Tyr667Cys 1 0 − + C-terminal
Benign variants
c.332C>T p.Ala111Val 1 0 − − Polypeptide linker




c.523A>G p.Ser175Glye 0 1 ++ + Polypeptide linker
Benign variants
c.1057A>G p.Ile353Val 1 0 − − Polypeptide linker
c.1147A>G p.Ile384Val 1 0 − − Polypeptide linker
c.1921G>A p.Ala641Thr 1 0 − − C-terminal
Total 3 1
DVL2+DVL3 variants 9 2
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coordinates cell proliferation and patterning, and the PCP
pathway, which coordinates cell polarity within a sheet of
cells and also directs convergent extension movements and
neurulation in vertebrates. Evidence for the involvement of
the DVLs genes as well as others core PCP genes in neuru-
lation have emerged from studies of a wide range of mutants
of orthologs of PCP genes in several animal models.
Recently, we and other groups have demonstrated the link
between some of the PCP genes, such as VANGL1,
VANGL2, PRICKLE1, CELSR1, and FZD6, and human
NTDs (Kibar et al. 2007b, 2009, 2011; Bosoi et al. 2011;
Allache et al. 2012; De Marco et al. 2012).
In this study, we analyzed the role of DVL2 and DVL3 in
a large group of 473 NTD patients and 150 controls to
determine whether mutations at these genes predispose to
these birth defects. Prediction and understanding of the
downstream effects of the nonsynonymous variants was
done using computational methods.
An overall low mutation burden both in patients and
controls was found probably due to the pivotal role of
DVL proteins in biological processes, so that highly dam-
aging mutations or changing in critical and conserved posi-
tions essential for the structure and/or function of the protein
are not tolerated. We suggested that mutations at fully con-
served sites of DVL proteins may be lethal, thus accounting
for their relative absence in data sets, while those at moder-
ately conserved sites are more likely to produce the ob-
served disease phenotype in patients.
Nevertheless, we identified a total of seven rare (MAF
>1 %) missense mutations in seven patients that were
uniquely present in patients and absent in all controls ana-
lyzed and two of them, p.Tyr667Cys and p.Ala53Val, in
DVL2 were predicted to be detrimental in silico and were
detected in two sporadic cases of NTDs. Importantly, we
also identified a 1-bp insertion (c.1801_1802insG) in exon
15 of DVL2 predicted to lead to a premature truncation
(p.Glu620X) of the protein that lacks its C-terminal tail.
Although the impact of this variant will need to be evaluat-
ed, it is probably that the truncated form of the protein could
affect intracellular interactions or alternatively could play a
dominant negative role by inhibiting the wild-type protein.
Genotype–phenotype correlation shows that the DVL2
frame-shift mutation is associated with a complex dysra-
phism in a patient presenting with caudal agenesis and
tethered cord.
The identification of rare functional variants in DVL2
suggests an independent role of this gene in the pathogen-
esis of a minority of NTD patients and underscores the value
of candidate gene resequencing to understand the genetic
contribution in these birth defects. However, the absence of
a statistically significant burden of rare pathogenic muta-
tions of DVL2 in cases versus controls in our population
may be attributed to the occurrence of rare variants, having
frequencies too low to be able to run adequate statistical
comparisons. A much larger case–control mutation burden
analysis would be needed to answer this important question.
All the pathogenic DVL2 mutations were identified in
sporadic cases without reported family history and were
private. When the parents were available, the mutation was
inherited from an unaffected parent, demonstrating incom-
plete penetrance of the mutations.
Our findings suggest that DVL2 gene could contribute in
the pathogenesis of both open and closed forms of NTDs, as
reported for other PCP genes (Kibar et al. 2007b Kibar et al.
2009; Kibar et al. 2011), further supporting a common
mechanism involving defective PCP genes in the onset of
both NTD forms.
By contrast, we could not demonstrate a significant con-
tribution of DVL3 gene in the pathogenesis of NTDs. In fact,
although the p.Ile353Val and p.Ile384Val missense variants
affect residues conserved across the evolution, both muta-
tions did not have an evident pathogenic effect on protein
function. Further studies would be required to determine
whether DVL3 may play an independent role in the devel-
opment of NTDs.
A predominant role of DVL2 over DVL3 is in agreement
with mouse models demonstrating that Dvl2 is the most
important gene to promote neural tube closure and is suffi-
cient by itself for correct closure. In fact, Dvl1 and Dvl3 are
not sufficient by themselves but contribute significantly to
neural tube closure only when Dvl2 is completely missing
(Wang et al. 2006). The discrepancy between human and
mouse models is represented by the phenotype resulting
from gene inactivation; differently from humans where we
found DVL2 mutations mainly in closed forms of NTDs,
knockouts in Dvl2 gene have been implicated only in open
forms of NTDs including spina bifida and craniorachischi-
sis. In general, the role of a defective PCP signaling in
closed forms of NTDs in mouse models has not been inves-
tigated yet.
Interestingly, we provide evidences of digenic occurrence
of mutations at two core PCP genes, one of the two DVL
genes and a second core PCP gene. In fact, we identified
two patients that were double heterozygote for missense
variants in DVL2 and VANGL2 (DVL2 p.Thr535Ile/
Table 2 Patients carrying variants both in DVLs genes and in a second
core PCP gene
DVL variant PCP gene variants Clinical phenotype
DVL2 p.Thr535Ile VANGL2 p. Arg135Trpa MMC
DVL2 p. Glu620X VANGL2 p. Arg482Hisa CA
DVL2 p. Ala111Val CELSR1 p.Thr346Serb Lipoma
DVL3 p. Ile353Val VANGL1 p. Ala404Serc CA
a Kibar et al. 2011; b Allache et al. 2012; c Kibar et al. 2009
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VANGL2 p.Arg135Trp; DVL2 p. Glu620X/VANGL2
p.Arg482His), one patient in DVL2 and CELSR1 (DVL2
p.Ala111Val/CELSR1 p. Thr346Ser), and last one in DVL3
and VANGL1 (DVL3 p.Ile353Val/VANGL1 p.Ala404Ser).
Genetic interactions between core PCP genes have been
demonstrated in double mutant mice developing alteration
of neural tissue closure processes, including both open
rostral and caudal neural tube defects (Harris and Juriloff
2010; Yu et al. 2010). According to the multifactorial model
of human NTD etiology, here we report that human DVL
mutations may genetically interact with VANGL and
CELSR1 alleles to affect neural tube closure, although we
could not exclude that two mutations in the same individual
may be a coincidental finding. Replication of our findings in
larger sample sets will, however, be required to further
substantiate the observed effects.
In conclusion, to our knowledge, this study is the first
describing a comprehensive resequencing analysis of the
DVL genes in NTDs. Our findings support the involvement
of rare DVL2 variants in NTD etiology and emphasize the
role of PCP genes in neural tube closure. Moreover, poten-
tial genetic interactions of mutations in more than one PCP
gene represent a further step forward to our understanding of
the intricate genetic puzzle underlying these complex mal-
formations. Further screening of DVL3 gene and genetic
analysis of DVL1 is warranted. Finally, functional studies
of the DVL variants are needed to confirm their implication
in NTDs risk.
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